Geneos Wealth Management’s Cognizant CTSH Stock Holding History

Geneos Wealth Management’s Portfolio CTSH Stock Details CTSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.42K	Sell	72 -54	-43%	-$3.86K	﹤0.01%	2184
2025 Q4	$10.5K	Sell	126 -24	-16%	-$1.8K	﹤0.01%	1952
2025 Q3	$10.1K	Sell	150 -493	-77%	-$35.6K	﹤0.01%	1962
2025 Q2	$50.2K	Sell	643 -701	-52%	-$53.7K	﹤0.01%	1568
2025 Q1	$103K	Buy	1,344 +1,084	+417%	+$88.2K	﹤0.01%	1560
2024 Q4	$20K	Hold	260	–	–	﹤0.01%	1725
2024 Q3	$20.1K	Buy	260 +188	+261%	+$14K	﹤0.01%	1557
2024 Q2	$4.9K	Sell	72 -25	-26%	-$1.7K	﹤0.01%	1725
2024 Q1	$7.11K	Sell	97 -21	-18%	-$1.6K	﹤0.01%	1632
2023 Q4	$8.91K	Sell	118 -493	-81%	-$34K	﹤0.01%	1577
2023 Q3	$41.4K	Hold	611	–	–	﹤0.01%	1130
2023 Q2	$39.9K	Sell	611 -1,144	-65%	-$70.9K	﹤0.01%	1148
2023 Q1	$107K	Hold	1,755	–	–	0.01%	826
2022 Q4	$100K	Hold	1,755	–	–	0.01%	824
2022 Q3	$100K	Buy	1,755 +364	+26%	+$23.8K	0.01%	800
2022 Q2	$94K	Buy	1,391 +450	+48%	+$34.4K	﹤0.01%	1027
2022 Q1	$84K	Sell	941 -45	-5%	-$3.95K	﹤0.01%	1151
2021 Q4	$87K	Hold	986	–	–	﹤0.01%	1224
2021 Q3	$74K	Sell	986 -70	-7%	-$5.16K	﹤0.01%	1296
2021 Q2	$73K	Sell	1,056 -444	-30%	-$33.1K	﹤0.01%	1304
2021 Q1	$120K	Hold	1,500	–	–	﹤0.01%	1212
2020 Q4	$83K	Buy	1,500 +455	+44%	+$34.6K	﹤0.01%	1211
2020 Q3	$71K	Buy	1,045 +13	+1%	+$846	﹤0.01%	1088
2020 Q2	$56K	Hold	1,032	–	–	﹤0.01%	1166
2020 Q1	$48K	Sell	1,032 -407	-28%	-$24.3K	﹤0.01%	1125
2019 Q4	$89K	Hold	1,439	–	–	﹤0.01%	988
2019 Q3	$84K	Sell	1,439 -3,842	-73%	-$243K	0.01%	954
2019 Q2	$334K	Buy	5,281 +1,042	+25%	+$68.4K	0.02%	516
2019 Q1	$307K	Buy	4,239 +629	+17%	+$44K	0.02%	521
2018 Q4	$227K	Buy	3,610 +18	+0.5%	+$1.25K	0.02%	562
2018 Q3	$277K	Buy	3,592 +67	+2%	+$5.24K	0.02%	537
2018 Q2	$278K	Hold	3,525	–	–	0.02%	469
2018 Q1	$283K	Sell	3,525 -8	-0.2%	-$632	0.02%	437
2017 Q4	$250K	Hold	3,533	–	–	0.02%	474
2017 Q3	$256K	Sell	3,533 -92	-3%	-$6.46K	0.03%	443
2017 Q2	$240K	Sell	3,625 -2	-0.1%	-$127	0.02%	448
2017 Q1	$215K	Sell	3,627 -6	-0.2%	-$345	0.02%	464
2016 Q4	$203K	Hold	3,633	–	–	0.03%	454
2016 Q3	$173K	Buy	3,633 +36	+1%	+$2.05K	0.02%	474
2016 Q2	$205K	Hold	3,597	–	–	0.03%	434
2016 Q1	$227K	Buy	+3,597	New	+$209K	0.03%	405

Other funds holding CTSH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geneos Wealth Management's CTSH Position: Q1 2026 in Review

Geneos Wealth Management reduced its Cognizant (CTSH) stake by 43% in Q1 2026, selling an estimated $3.86K and leaving 72 shares worth $4.42K. The position accounts for ﹤0.01% of the portfolio, ranked #2184.

Geneos Wealth Management first reported a position in CTSH in Q1 2016 and has held it in 41 quarters since. The position peaked at $334K in Q2 2019. 985 funds tracked by Wall St. Rank hold CTSH as of Q1 2026.

Geneos Wealth Management held 72 shares of Cognizant worth $4.42K as of Q1 2026.
Geneos Wealth Management sold 54 Cognizant shares in Q1 2026, an estimated $3.86K.
Cognizant made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #2184 holding.
Geneos Wealth Management first reported a position in Cognizant in Q1 2016 and has held it in 41 quarters since.
Geneos Wealth Management's Cognizant position peaked at $334K in Q2 2019.
985 funds tracked by Wall St. Rank held Cognizant as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.